RESUMO
Objective To explore the value of contrast?enhanced T1 mapping technique in differentiating between recurrence and radiation necrosis of brain metastases after gamma knife treatment. Methods From March 2016 to June 2017,56 patients with brain metastases treated by gamma knife and confirmed by pathology or follow?up in Shandong Provincial Hospital were prospectively collected. Routine MRI and contrast?enhanced T1 mapping sequence scan were performed. T1 value was obtained 5 mins (T1 5 min) and 60 mins (T1 60 min) after injection of contrast agent. The Differences betweenT1 60 min and T1 5 min (T1 differ) was calculated,and relative cerebral blood volume (rCBV) value was obtained. Patients were divided into radiation necrosis group and tumor recurrence group according to imaging follow?up results or pathological results. Two?sides unpaired t test was used to compare the differences in T1 5 min,T1 60 min,T1 differ and rCBV between the 2 groups. Pearson correlation analysis was used to evaluate the correlation between T1 differ and rCBV, and the receiving operating curve (ROC) was used to evaluate the diagnostic efficiency of MRI quantitative parameters,and Z test was used to compare the differences of area under curve (AUC) between T1 differ and rCBV values. Results Of the 56 patients,27 had tumor recurrence and 29 had radiation necrosis. The differences in T1 5 min,T1 60 min,T1 differ and rCBV between the 2 groups was statistically significant (P<0.05). T1 differ and rCBV values were significantly correlated, r=0.58, P<0.01. The differential diagnosis of AUC between radiation necrosis and tumor recurrence were 0.66,0.73,0.97 and 0.95 respectively in T1 5 min,T1 60 min, T1 differ and rCBV, and there was no significant differences between AUC in T1 differ and rCBV (P=0.274). Conclusion The contrast?enhanced T1 mapping image can be used for differential diagnosis between radiation necrosis and recurrence after gamma knife treatment of brain metastases. T1 differ value has high differential efficiency.
RESUMO
Objective To evaluate the effect of the different Child-Pugh classification on the recurrence and survival of hepatocellular carcinoma (HCC) recipients after liver transplantation. Methods Clinical data of 125 HCC recipients undergoing liver transplantation were retrospectively analyzed. The 3-year disease-free survival (DFS) and overall survival (OS) rates were calculated by Kaplan-Meier survival curve. The independent risk factors probably affecting the recurrence and survival of HCC recipients after liver transplantation were identified by using Cox's proportional hazards regression model. Results The median follow-up time was 25.6 months. The 3-year DFS and OS rates were 68.4% and 65.7% for all patients. The 3-year DFS and OS rates in 113 patients with Child-Pugh class A/B HCC were 68.6% and 66.2%, whereas 66.7% and 65.6% for 12 patients with Child-Pugh class C HCC with no statistical significance (all P>0.05). Cox's proportional hazards regression model demonstrated that vascular invasion (P=0.001)and the number of tumors>3 (P=0.025) were the independent risk factors for the postoperative recurrence of HCC in recipients undergoing liver transplantation. Alpha fetoprotein (AFP)>400μg/L (P=0.035), vascular invasion (P=0.031) and number of tumors>3 (P=0.008) were the independent risk factors affecting the survival of HCC patients. Conclusions The postoperative prognosis does not significantly differ between Child-Pugh class C and A/B HCC patients after liver transplantation. AFP, vascular invasion and number of tumors are the risk factors affecting the clinical prognosis of HCC patients after liver transplantation. Liver transplantation is an efficacious treatment for HCC patients with Child-Pugh class C.